342 related articles for article (PubMed ID: 30134541)
1. HCN Channels: New Therapeutic Targets for Pain Treatment.
Ramírez D; Zúñiga R; Concha G; Zúñiga L
Molecules; 2018 Aug; 23(9):. PubMed ID: 30134541
[TBL] [Abstract][Full Text] [Related]
2. Hyperpolarization-activated and cyclic nucleotide-gated channel proteins as emerging new targets in neuropathic pain.
He JT; Li XY; Zhao X; Liu X
Rev Neurosci; 2019 Jul; 30(6):639-649. PubMed ID: 30768426
[TBL] [Abstract][Full Text] [Related]
3. HCN Channel as Therapeutic Targets for Heart Failure and Pain.
Cao Y; Pang J; Zhou P
Curr Top Med Chem; 2016; 16(16):1855-61. PubMed ID: 26667117
[TBL] [Abstract][Full Text] [Related]
4. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy.
Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A
Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292
[TBL] [Abstract][Full Text] [Related]
5. Neurophysiology of HCN channels: from cellular functions to multiple regulations.
He C; Chen F; Li B; Hu Z
Prog Neurobiol; 2014 Jan; 112():1-23. PubMed ID: 24184323
[TBL] [Abstract][Full Text] [Related]
6. The impact of hyperpolarization-activated cyclic nucleotide-gated (HCN) and voltage-gated potassium KCNQ/Kv7 channels on primary microglia function.
Vay SU; Flitsch LJ; Rabenstein M; Monière H; Jakovcevski I; Andjus P; Bijelic D; Blaschke S; Walter HL; Fink GR; Schroeter M; Rueger MA
J Neuroinflammation; 2020 Apr; 17(1):100. PubMed ID: 32248813
[TBL] [Abstract][Full Text] [Related]
7. Peripheral hyperpolarization-activated cyclic nucleotide-gated channels contribute to inflammation-induced hypersensitivity of the rat temporomandibular joint.
Hatch RJ; Jennings EA; Ivanusic JJ
Eur J Pain; 2013 Aug; 17(7):972-82. PubMed ID: 23255289
[TBL] [Abstract][Full Text] [Related]
8. Hyperpolarization-activated cyclic-nucleotide-gated channels potentially modulate axonal excitability at different thresholds.
Weerasinghe D; Menon P; Vucic S
J Neurophysiol; 2017 Dec; 118(6):3044-3050. PubMed ID: 28904107
[TBL] [Abstract][Full Text] [Related]
9. Involvement of hyperpolarization-activated, cyclic nucleotide-gated cation channels in dorsal root ganglion in neuropathic pain.
Wan Y
Sheng Li Xue Bao; 2008 Oct; 60(5):579-80. PubMed ID: 18958363
[TBL] [Abstract][Full Text] [Related]
10. Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders.
Santoro B; Shah MM
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():109-131. PubMed ID: 31914897
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hyperpolarization-activated cyclic nucleotide-gated channels with natural flavonoid quercetin.
Liang Y; Xu Z; Wu X; Pang J; Zhou P; Cao Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):952-957. PubMed ID: 33008592
[TBL] [Abstract][Full Text] [Related]
12. cAMP-PKA signaling is involved in regulation of spinal HCN channels function in diabetic neuropathic pain.
Ma Y; Chen J; Yu D; Wei B; Jin H; Zeng J; Liu X
Neurosci Lett; 2021 Apr; 750():135763. PubMed ID: 33617945
[TBL] [Abstract][Full Text] [Related]
13. Hyperpolarization-activated cyclic nucleotide-gated channels may contribute to regional anesthetic effects of lidocaine.
Zhou C; Ke B; Zhao Y; Liang P; Liao D; Li T; Liu J; Chen X
Anesthesiology; 2015 Mar; 122(3):606-18. PubMed ID: 25485469
[TBL] [Abstract][Full Text] [Related]
14. HCN channels and absence seizures.
Crunelli V; David F; Morais TP; Lorincz ML
Neurobiol Dis; 2023 Jun; 181():106107. PubMed ID: 37001612
[TBL] [Abstract][Full Text] [Related]
15. [Xylazine Produced Analgesic Effect via Inhibits Hyperpolarization-activated Cyclic Nucleotide-gated Ion Channels Currents].
Chen FF; Li L; Chen XD; Zhou C; Liao DQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):20-26. PubMed ID: 31037900
[TBL] [Abstract][Full Text] [Related]
16. HCN Channels Modulators: The Need for Selectivity.
Novella Romanelli M; Sartiani L; Masi A; Mannaioni G; Manetti D; Mugelli A; Cerbai E
Curr Top Med Chem; 2016; 16(16):1764-91. PubMed ID: 26975509
[TBL] [Abstract][Full Text] [Related]
17. Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitability.
Spinelli V; Sartiani L; Mugelli A; Romanelli MN; Cerbai E
Can J Physiol Pharmacol; 2018 Oct; 96(10):977-984. PubMed ID: 29969572
[TBL] [Abstract][Full Text] [Related]
18. The Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels.
Sartiani L; Mannaioni G; Masi A; Novella Romanelli M; Cerbai E
Pharmacol Rev; 2017 Oct; 69(4):354-395. PubMed ID: 28878030
[TBL] [Abstract][Full Text] [Related]
19. Cardiac and neuronal HCN channelopathies.
Rivolta I; Binda A; Masi A; DiFrancesco JC
Pflugers Arch; 2020 Jul; 472(7):931-951. PubMed ID: 32424620
[TBL] [Abstract][Full Text] [Related]
20. Structural mechanism for the regulation of HCN ion channels by the accessory protein TRIP8b.
DeBerg HA; Bankston JR; Rosenbaum JC; Brzovic PS; Zagotta WN; Stoll S
Structure; 2015 Apr; 23(4):734-44. PubMed ID: 25800552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
